Gene · 3003
Papers2,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 2,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Immunology of DLBCL. | Cancers (Basel) | 2023 | 36765793 | PubTator, text mining | PubMed |
| Cell-cell communications shape tumor microenvironment and predict clinical outcomes in clear cell renal carcinoma. | J Transl Med | 2023 | 36765369 | PubTator, text mining | PubMed |
| Eomes is sufficient to regulate IL-10 expression and cytotoxic effector molecules in murine CD4+ T cells. | Front Immunol | 2023 | 36756120 | PubTator, text mining | PubMed |
| Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses. | Nat Commun | 2023 | 36750562 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomics reveal aberrant lymphoid developmental programs driving granuloma formation. | Immunity | 2023 | 36750099 | PubTator, text mining | PubMed |
| CoV2-TCR: A web server for screening TCR CDR3 from TCR immune repertoire of COVID-19 patients and their recognized SARS-CoV-2 epitopes. | Comput Struct Biotechnol J | 2023 | 36741787 | PubTator, text mining | PubMed |
| Nucleolin mediates SARS-CoV-2 replication and viral-induced apoptosis of host cells. | Antiviral Res | 2023 | 36740097 | PubTator, text mining | PubMed |
| VEGF-A enhances the cytotoxic function of CD4+ cytotoxic T cells via the VEGF-receptor 1/VEGF-receptor 2/AKT/mTOR pathway. | J Transl Med | 2023 | 36737819 | PubTator, text mining | PubMed |
| Incorporating knowledge of disease-defining hub genes and regulatory network into a machine learning-based model for predicting treatment response in lupus nephritis after the first renal flare. | J Transl Med | 2023 | 36737814 | PubTator, text mining | PubMed |
| Exploring the pathogenesis and immune infiltration in dilated cardiomyopathy complicated with atrial fibrillation by bioinformatics analysis. | Front Immunol | 2023 | 36733486 | PubTator, text mining | PubMed |
| Multimodal single-cell analyses of peripheral blood mononuclear cells of COVID-19 patients in Japan. | Sci Rep | 2023 | 36732528 | PubTator, text mining | PubMed |
| Relationships of tumor differentiation and immune infiltration in gastric cancers revealed by single-cell RNA-seq analyses. | Cell Mol Life Sci | 2023 | 36729271 | PubTator, text mining | PubMed |
| CD8+ CD226high T cells in liver metastases dictate the prognosis of colorectal cancer patients treated with chemotherapy and radical surgery. | Cell Mol Immunol | 2023 | 36717657 | PubTator, text mining | PubMed |
| Targeted inhibition of RBPJ transcription complex alleviates the exhaustion of CD8+ T cells in hepatocellular carcinoma. | Commun Biol | 2023 | 36717584 | PubTator, text mining | PubMed |
| Single-cell RNA-sequencing reveals radiochemotherapy-induced innate immune activation and MHC-II upregulation in cervical cancer. | Signal Transduct Target Ther | 2023 | 36710358 | PubTator, text mining | PubMed |
| Immune checkpoint receptors in autoimmunity. | Curr Opin Immunol | 2023 | 36709596 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Esophageal Squamous Cell Carcinoma. | Adv Sci (Weinh) | 2023 | 36709495 | PubTator, text mining | PubMed |
| Risk modeling of single-cell transcriptomes reveals the heterogeneity of immune infiltration in hepatocellular carcinoma. | J Biol Chem | 2023 | 36708920 | PubTator, text mining | PubMed |
| Depletion of polyfunctional CD26highCD8+ T cells repertoire in chronic lymphocytic leukemia. | Exp Hematol Oncol | 2023 | 36707896 | PubTator, text mining | PubMed |
| Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression. | Sci Adv | 2023 | 36706185 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/papers?page=42